C12N 2830/005
Repressible enhancer/promoter combination
Official title: repressible enhancer/promoter combination, e.g. KRAB
C12N2830/005 (Repressible enhancer/promoter combination) appears on 200 US grants and 270 published applications in this corpus.
Search patents in C12N- Granted patents
- 200
- Published applications
- 270
- Assignees
- 162
- Inventors
- 557
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 11 | 0 |
| 1999 | 12 | 0 |
| 2000 | 9 | 0 |
| 2001 | 8 | 3 |
| 2002 | 9 | 9 |
| 2003 | 8 | 20 |
| 2004 | 3 | 14 |
| 2005 | 6 | 9 |
| 2006 | 3 | 13 |
| 2007 | 6 | 7 |
| 2008 | 5 | 9 |
| 2009 | 3 | 8 |
| 2010 | 9 | 14 |
| 2011 | 9 | 5 |
| 2012 | 5 | 12 |
| 2013 | 3 | 10 |
| 2014 | 6 | 9 |
| 2015 | 9 | 5 |
| 2016 | 10 | 6 |
| 2017 | 6 | 16 |
| 2018 | 8 | 10 |
| 2019 | 3 | 4 |
| 2020 | 5 | 17 |
| 2021 | 6 | 13 |
| 2022 | 1 | 11 |
| 2023 | 13 | 8 |
| 2024 | 10 | 17 |
| 2025 | 3 | 16 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Phosphate sensing microbial gene switch9 Jun 2026US 12,649,699 B2Switch Bioworks, Inc.
- Adeno-associated virus (AAV) producer cell line and related methods20 Jan 2026US 12,529,074 B2Lonza Walkersville, Inc.
- Generation regulatable fusogenic oncolytic herpes simplex virus type 1 virus and methods of use30 Dec 2025US 12,509,662 B2The Brigham and Women's Hospital, Inc.
- Single-vector Type I vectors2 Sep 2025US 12,404,513 B2SNIPR Biome ApS
- Expression vector and method20 May 2025US 12,305,185 B2Mount Spec Investments Pty Ltd
- A method for detecting protein targets of an enzyme using a biotin ligase20 Aug 2026US 2026/0243776 A1Leibniz-Institut Fur Alternsforschung—Fritz-Lipmann-Institut E.V. (Fli)
- Tet-r expression cassettes and cell lines16 Jul 2026US 2026/0201417 A1Cevec Pharmaceuticals GmbH
- Lipid nanoparticles for bioproduction30 Apr 2026US 2026/0117187 A1
- Systems for production of transducing particles, methods, kits, compositions and uses thereof26 Mar 2026US 2026/0083787 A1Ramot at Tel-Aviv University Ltd.
- Single-vector type i vectors22 Jan 2026US 2026/0022389 A1SNIPR Biome ApS
Most cited
By later US patents
- Regulation of endogenous gene expression in cells using zinc finger proteins648US 6,534,261 B1Sangamo BioSciences, Inc. · 2003
- Regulation of endogenous gene expression in cells using zinc finger proteins395US 6,824,978 B1Sangamo BioSciences, Inc. · 2004
- Modulation of endogenous gene expression in cells383US 6,933,113 B2Sangamo BioSciences, Inc. · 2005
- Regulation of endogenous gene expression in cells using zinc finger proteins367US 6,607,882 B1Sangamo BioSciences, Inc. · 2003
- Regulation of endogenous gene expression in cells using zinc finger proteins363US 6,979,539 B2Sangamo BioSciences, Inc. · 2005